Moreover, higher CEP20 protein levels were associated with increased lymph nodes and distant metastasis, indicating that CEP20 upregulation is associated with a worse prognosis for patients with NSCLC. This evidence concerns the gene CEP20 and non-small cell lung carcinoma.